Skip to Content
 
Center for International Blood and Marrow Transplant Research

IN16-02

Main Content

Determination of the burden of mucosal barrier injury-laboratory confirmed bloodstream infections in the first 100 days after stem cell transplant.

Study #: IN16-02

Study Status: Published

Presentation(s)

2018, ASH (Poster)

Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury-laboratory confirmed bloodstream infections in the first 100 days after allogeneic hematopoietic stem cell transplant.

Citation

Dandoy CE, Kim S, Chen M, Ahn K-W, Ardura MI, Brown V, Chhabra S, Diaz MA, Dvorak C, Farhadfar N, Flagg A, Ganguly S, Hale GA, Hashmi SK, Hematti P, Martino R, Nishihori T, Nusrat R, Olsson RF, Rotz SJ, Sung AD, Perales M-A, Lindemans CA, Komanduri KV, Riches ML.

JAMA Network Open. 2020, Jan 03: 3(1): 3(1):e1918668. doi: 10.1001/jamanetworkopen.2019.18668. Epub 2020, Jan 08. PMCID:PMC6991246.

PubMed

PMID: 31913492

Abstract